Neutropenia News and Research

RSS
Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils, the most important type of white blood cell, in the blood.
Comprehensive analysis outlines the potential toxicities of antibody drug conjugates

Comprehensive analysis outlines the potential toxicities of antibody drug conjugates

AI-guided tools pinpoint immune cell driver and protective genetic factor for esophageal cancer

AI-guided tools pinpoint immune cell driver and protective genetic factor for esophageal cancer

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

Vertical transmission of SARS-CoV-2 uncommon

Vertical transmission of SARS-CoV-2 uncommon

Drugs targeting DNA damage response pathway show therapeutic potential against advanced solid tumors

Drugs targeting DNA damage response pathway show therapeutic potential against advanced solid tumors

New oral pill for COVID-19 home treatment

New oral pill for COVID-19 home treatment

mRNA BNT162b2 vaccine safe in immunocompromised patients

mRNA BNT162b2 vaccine safe in immunocompromised patients

Combination of chemotherapy and immune checkpoint inhibitors shows promise in NSCLC patients with untreated brain metastases

Combination of chemotherapy and immune checkpoint inhibitors shows promise in NSCLC patients with untreated brain metastases

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

Combination of investigational therapeutic and chemotherapy shows promise for AML treatment

Gene variant in African Americans contributes to unnecessary bone marrow biopsies

Gene variant in African Americans contributes to unnecessary bone marrow biopsies

ATS publishes new clinical practice guideline on community-acquired pneumonia

ATS publishes new clinical practice guideline on community-acquired pneumonia

New NCCN patient guidelines on anemia and neutropenia published

New NCCN patient guidelines on anemia and neutropenia published

CAR T-cell therapy triples expected length of remission for relapsed multiple myeloma patients

CAR T-cell therapy triples expected length of remission for relapsed multiple myeloma patients

FDA approves drug to reduce frequency of chemotherapy-induced bone marrow suppression

FDA approves drug to reduce frequency of chemotherapy-induced bone marrow suppression

Physicians receive Pfizer Prize for research on leukemia, cardiac arrhythmias

Physicians receive Pfizer Prize for research on leukemia, cardiac arrhythmias

New taxonomic classification of non-skeletal rare congenital disorders with impact on bone physiology

New taxonomic classification of non-skeletal rare congenital disorders with impact on bone physiology

Novel antibody-drug conjugate shows 29% response rate in rare blood cancer

Novel antibody-drug conjugate shows 29% response rate in rare blood cancer

Researchers evaluate safety of novel therapy for patients with non-Hodgkin lymphoma

Researchers evaluate safety of novel therapy for patients with non-Hodgkin lymphoma